Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05150210 · ClinicalTrials.gov registry record · NA

SP Thoracic IDE Study

A NA study of Myasthenia Gravis and Thymoma, sponsored by Intuitive Surgical.

Active
Registry status
NA
Development phase
32
Enrollment target
6
Study locations

NCT05150210 is a NA study of Myasthenia Gravis and Thymoma that is active but no longer recruiting, run by Intuitive Surgical. The registered enrollment target is 32 participants, below the 190-participant average among 32 other Myasthenia Gravis trials with a reported enrollment target (83% lower). The trial reports 6 study locations across 5 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05150210, a NA study of Myasthenia Gravis and Thymoma, is active but no longer recruiting, sponsored by Intuitive Surgical.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
32 participants
Enrollment target
6
Study locations

Study Summary

To confirm the safety and performance of the da Vinci SP Surgical System, Instruments and Accessories in pulmonary lobectomy, and in thymectomy procedures.

Interventions

  • DEVICE Robotic-Assisted Surgery

Study Locations (6)

New York

  • NYU Langone Health - New York
  • Memorial Sloan Kettering Cancer Center - New York

California

  • Cedars-Sinai Medical Center - Los Angeles

Massachusetts

  • Brigham and Women's Hospital - Boston

North Carolina

  • Duke University Hospital - Durham

Texas

  • MD Anderson Cancer Center - Houston

Trial Details

FieldValue
Enrollment Target 32 participants
Start Date 2022-07-20
Est. Completion 2028-07
Phase NA

Sponsor

Intuitive Surgical

40 total trials

What the Registry Record Tells You About NCT05150210

The ClinicalTrials.gov registry entry for NCT05150210 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 190-participant average among 32 other Myasthenia Gravis trials with a reported enrollment target (83% lower). The listed sponsor is Intuitive Surgical, which has 40 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Myasthenia Gravis appearing as the primary indexed condition, and to 1 intervention - of which Robotic-Assisted Surgery is the first listed.

NCT05150210 reports 6 study locations spanning 5 distinct geographic areas - top geographies include New York, California, Massachusetts.

Frequently Asked Questions

What is clinical trial NCT05150210 about?

NCT05150210 is a clinical study titled "SP Thoracic IDE Study". To confirm the safety and performance of the da Vinci SP Surgical System, Instruments and Accessories in pulmonary lobectomy, and in thymectomy procedures.

What is the current status of trial NCT05150210?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 32 participants. The study started on 2022-07-20. Estimated completion is 2028-07.

What conditions does trial NCT05150210 study?

This clinical trial studies the following conditions: Myasthenia Gravis, Thymoma, Primary Lung Cancer, Benign Lung Disease.

What interventions are being tested in trial NCT05150210?

The interventions under investigation include: Robotic-Assisted Surgery (DEVICE).

Who is sponsoring clinical trial NCT05150210?

This trial is sponsored by Intuitive Surgical, which has 40 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05150210 being conducted?

This trial has 6 study locations across California, Massachusetts, New York, North Carolina, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Myasthenia Gravis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.